Expedited PublicationThe Pathology of Neoatherosclerosis in Human Coronary Implants: Bare-Metal and Drug-Eluting Stents
Under an Elsevier user license
open archive
Key Words
bare-metal stent
drug-eluting stent
neoatherosclerosis
pathology
Abbreviations and Acronyms
BMS
bare-metal stent(s)
CAD
coronary artery disease
CI
confidence interval
DES
drug-eluting stent(s)
GEE
generalized estimating equations
IQR
interquartile range
LST
late stent thrombosis
OR
odds ratio
PCI
percutaneous coronary interventions
PES
paclitaxel-eluting stent(s)
SES
sirolimus-eluting stent(s)
VLST
very late stent thrombosis
Cited by (0)
CVPath Institute provided full support for this work. Dr. Finn is supported by National Institutes of Health grant HL096970-01A1, the Carlyle Fraser Heart Center at Emory University, and a sponsored research agreement with Medtronic and St. Jude Medical; and is a consultant for Abbott Vascular and Cordis. Dr. Virmani receives research support from Medtronic AVE, Abbott Vascular, Atrium Medical, OrbusNeich Medical, Terumo Corporation, Cordis Corporation, BioSensors International, Biotronik, and Alchimedics; and is a consultant for Medtronic AVE, Abbott Vascular, W.L. Gore, Atrium Medical, and Lutonix. All other authors have reported that they have no relationships to disclose. Drs. Nakazawa and Otsuka contributed equally to this work.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.